Reporting Season: Zenith reports 'outstanding' annual results

Published 06-AUG-2018 10:00 A.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Name: Zenith Energy Ltd (ASX:ZEN)

Market Cap: $94 million

Last Closing Share Price: $1.19

Leading independent power producer, Zenith Energy Ltd (ASX:ZEN) has generated a Net Profit After Tax (NPAT) of $8.47 million for fiscal 2018 from revenues of $51.4 million, up 64 percent on fiscal 2017.

The result could be well received as it significantly outperformed the FY18 earnings forecast of $3.52 million contained in the prospectus, and it also represented year-on-year growth of 171 percent.

The net profit represents earnings per share of 8.65 cents placing the company on a PE multiple of 13.7 compared with the sector average of 21.8.

Zen's overall performance has been impressive

The outperformance has been driven by continued contract wins and an expansion of its power generation capacity.

Managing Director, Hamish Moffat, said “The outstanding results are testament to the company’s successful delivery of innovative, reliable and cost-effective power generation solutions for its clients.”

However it is an early stage of this company’s development and if considering this stock for your portfolio you should take all public information into account and seek professional financial advice.

More than doubles contracted capacity

Zenith’s growing number of contracts has led to it more than doubling its build, own, operate contracted capacity from 88 megawatts when it listed on the ASX to 189 megawatts in August 2018.

Zenith currently has 12 contracts in place representing 420MW of generation capacity under control and a robust pipeline of remote power generation opportunities.

Significant new contracts secured over the last 12 months include the Tanami Gold Mine for Newmont Mining Corporation, the Dalgaranga project is one for Gascoyne Resources, and the Mt Morgans Gold Project for Dacian Gold.

Balance sheet and outlook strong

Zenith enters 2019 with a strong balance sheet, as well as the prospect of new contracts and extensions from existing clients.

The company announced last week that its wholly-owned subsidiary, Zenith Pacific (BWI) Pty Ltd, had executed a PPA to supply electricity and build, own, operate, maintain and upgrade equipment for a power station at the WA Oil Operations on Barrow Island.

While the company didn’t provide earnings guidance for 2019, management said that it was aiming to convert a significant proportion of its current 380 megawatt pipeline to contracted capacity, as well as exploring early opportunities in renewable power, smart grid and storage.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free